Glaser, Shannon

Dopaminergic inhibition of secretin-stimulated choleresis by increased PKC-gamma expression and decrease of PKA activity. [electronic resource] - American journal of physiology. Gastrointestinal and liver physiology Apr 2003 - G683-94 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

0193-1857

10.1152/ajpgi.00302.2002 doi


1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine--pharmacology
Acetophenones--pharmacology
Alkaloids
Animals
Benzophenanthridines
Benzopyrans--pharmacology
Bicarbonates--metabolism
Bile--metabolism
Bile Ducts, Intrahepatic--cytology
Chelating Agents--pharmacology
Cyclic AMP--metabolism
Cyclic AMP-Dependent Protein Kinases--metabolism
Dopamine--metabolism
Dopamine Agonists--pharmacology
Down-Regulation--drug effects
Egtazic Acid--analogs & derivatives
Enzyme Inhibitors--pharmacology
Epithelium--enzymology
Liver--enzymology
Male
Phenanthridines--pharmacology
Protein Kinase C--genetics
Quinolines--pharmacology
Rats
Rats, Inbred F344
Receptors, Dopamine D2--metabolism
Secretin--metabolism